# Study of AC-201 in Patients With Type 2 Diabetes Mellitus

> **NCT01276106** · PHASE2 · COMPLETED · sponsor: **TWi Biotechnology, Inc.** · enrollment: 259 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** AC-201, 25mg
- **DRUG:** AC-201, 50mg
- **DRUG:** AC-201, 75mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01276106
- **Lead sponsor:** TWi Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276106, "Study of AC-201 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01276106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*